» Articles » PMID: 36422367

Avian Oropharyngeal Trichomonosis: Treatment, Failures and Alternatives, a Systematic Review

Overview
Journal Microorganisms
Specialty Microbiology
Date 2022 Nov 24
PMID 36422367
Authors
Affiliations
Soon will be listed here.
Abstract

Oropharyngeal avian trichomonosis is a potentially lethal parasitic disease that affects several avian orders. This review is focused on the disease treatments since prophylactic treatment is prohibited in most countries and resistant strains are circulating. A systematic review following the PRISMA procedure was conducted and included 60 articles. Successful and non-toxic treatments of avian oropharyngeal trichomonosis started with enheptin, a drug replaced by dimetridazole, metronidazole, ornidazole, carnidazole and ronidazole. Administration in drinking water was the most employed and recommended method, although hierarchy of the avian flocks and palatability of the medicated water can interfere with the treatments. Besides pigeons, treatments with nitroimidazoles were reported in budgerigars, canaries, finches, bald eagles, a cinereous vulture and several falcon species, but resistant strains were reported mainly in domestic pigeons and budgerigars. Novel treatments include new delivery systems proved with traditional drugs and some plant extracts and its main components. Ethanolic extracts from ginger, curry leaf tree and , alkaloid extracts of and essential oils of and some Lamiaceae were highly active. Pure active compounds from the above extracts displayed good anti-trichomonal activity, although most studies lack a cytotoxicity or in vivo test.

Citing Articles

Comparative efficacy of eugenol, eugenol nanoemulsion, and metronidazole against : An experimental study.

Khaki A, Youssefi M, Nasrabadi N Open Vet J. 2024; 14(10):2618-2627.

PMID: 39545181 PMC: 11560258. DOI: 10.5455/OVJ.2024.v14.i10.11.


Epidemiological investigation of in beijing, China.

Jing S, Li Y, Li Q, Huang Y, Han S, Zhang Q Int J Parasitol Parasites Wildl. 2024; 24:100957.

PMID: 39035104 PMC: 11260024. DOI: 10.1016/j.ijppaw.2024.100957.

References
1.
Kucera J, Bedrnik P, Nastuneak J . [Verification of the therapeutic effects of ornidazole (1-(3-chloro-2-hydroxypropyl)-2-methyl-5-nitroimidazole) manufactured in Czechoslovakia in trichomoniasis in pigeons]. Vet Med (Praha). 1988; 33(9):551-6. View

2.
Franssen F, Lumeij J . In vitro nitroimidazole resistance of Trichomonas gallinae and successful therapy with an increased dosage of ronidazole in racing pigeons (Columba livia domestica). J Vet Pharmacol Ther. 1992; 15(4):409-15. DOI: 10.1111/j.1365-2885.1992.tb01032.x. View

3.
Tabari M, Youssefi M . and evaluations of essential oil activity against . Avicenna J Phytomed. 2018; 8(2):136-142. PMC: 5885327. View

4.
Zadravec M, Slavec B, Krapez U, Gombac M, Svara T, Poljsak-Prijatelj M . Trichomonosis outbreak in a flock of canaries (Serinus canaria f. domestica) caused by a finch epidemic strain of Trichomonas gallinae. Vet Parasitol. 2017; 239:90-93. DOI: 10.1016/j.vetpar.2017.04.001. View

5.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C . The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021; 10(1):89. PMC: 8008539. DOI: 10.1186/s13643-021-01626-4. View